Prelude Therapeutics Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2025 | 10.91 M | $15.71 M | 0.00% | 14.36% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 10.12 M | $14.58 M | 0.00% | 13.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.15 M | $1.65 M | 361.73% | 1.51% |
| VANGUARD GROUP INC | 11/07/2025 | 992.85 K | $1.43 M | 6.46% | 1.31% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 876.34 K | $1.26 M | -5.53% | 1.15% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 544.00 K | $783.36 K | -6.50% | 0.72% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 540.57 K | $777.00 K | 0.00% | 0.71% |
| MORGAN STANLEY | 11/14/2025 | 284.20 K | $409.25 K | -0.06% | 0.37% |
| BLACKROCK, INC. | 11/12/2025 | 264.97 K | $381.56 K | -38.74% | 0.35% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 222.70 K | $320.69 K | -1.02% | 0.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 217.57 K | $313.37 K | 0.00% | 0.29% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 160.65 K | $231.34 K | 0.00% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 152.23 K | $219.22 K | -1.77% | 0.20% |
| SHAY CAPITAL LLC | 11/14/2025 | 100.00 K | $144.00 K | 33.33% | 0.13% |
| STATE STREET CORP | 11/14/2025 | 97.59 K | $140.53 K | 0.00% | 0.13% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 79.33 K | $114.23 K | -46.82% | 0.10% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 75.16 K | $108.00 K | 5.30% | 0.10% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 69.25 K | $99.72 K | 0.00% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 53.50 K | $77.04 K | -39.55% | 0.07% |
| NORTHERN TRUST CORP | 11/14/2025 | 36.42 K | $52.45 K | -4.47% | 0.05% |
| JANE STREET GROUP, LLC | 11/14/2025 | 34.82 K | $50.14 K | -62.05% | 0.05% |
| CERITY PARTNERS LLC | 10/22/2025 | 34.33 K | $49.44 K | -5.66% | 0.05% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 25.84 K | $37.21 K | 100.00% | 0.03% |
| HRT FINANCIAL LP | 11/14/2025 | 16.90 K | $24.00 K | 100.00% | 0.02% |
| XTX TOPCO LTD | 11/14/2025 | 15.58 K | $22.43 K | -63.41% | 0.02% |
| HSBC HOLDINGS PLC | 11/13/2025 | 13.75 K | $20.21 K | -21.04% | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 10.50 K | $15.12 K | -75.94% | 0.01% |
| FMR LLC | 11/13/2025 | 9.10 K | $13.10 K | -18.52% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 8.85 K | $12.74 K | -21.65% | 0.01% |
| BARCLAYS PLC | 11/12/2025 | 8.71 K | $12.55 K | 1.28% | 0.01% |
| ROYAL BANK OF CANADA | 11/14/2025 | 7.71 K | $11.00 K | 172.80% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 6.93 K | $9.98 K | -58.77% | 0.01% |
| CITIGROUP INC | 11/10/2025 | 5.98 K | $8.60 K | 26.64% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 4.17 K | $6.01 K | -96.00% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 3.88 K | $5.59 K | 99.03% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 2.74 K | $3.95 K | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 1.63 K | $2.35 K | 0.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 1.22 K | $2.00 K | -69.63% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 1.17 K | $1.69 K | -0.76% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 500 | $720 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 89 | $128 | -39.86% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 52 | $75 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 11/10/2025 | 20 | $29 | 100.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 18 | $26 | -47.06% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 15 | $22 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| CANTOR FITZGERALD, L. P. | 12/01/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prelude Therapeutics Incorporated institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of Prelude Therapeutics Incorporated. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 10.91 M
BAKER BROS. ADVISORS LP: 10.12 M
MILLENNIUM MANAGEMENT LLC: 1.15 M
VANGUARD GROUP INC: 992,854
PRICE T ROWE ASSOCIATES INC /MD/: 876,338
RENAISSANCE TECHNOLOGIES LLC: 544,000
35.74% of Prelude Therapeutics Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 30.02 M shares in the last 24 months. This purchase volume represents approximately $43.82 M in transactions.